Wednesday's Top 10 Articles, Videos on TheStreet
NEW YORK (TheStreet) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today. Sign up for free email delivery of our daily Top 10.
Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon
Adam Feuerstein
Biotech columnist Adam Feuerstein responds to biotech stock questions posed by his Twitter followers. (Stocks include GILD, CHTP, DNDN ONXX)
More Biotech Twitter Mailbag: Orexigen, Affymax, YM Bio, Spectrum & More
Adam Feuerstein
Biotech columnist Adam Feuerstein responds to biotech stock questions posed by his Twitter followers.
Sirius Moves Closer to Being Bought (Update 1)
Chris Ciaccia
Liberty Media may double its stake to 80%, some analysts say.
Frank Byrt
Investors are better off balancing dividends and share-price appreciation. 3 Stocks Investors Are Selling but Should Be Buying
Andrea Tse
A 'contrarian' approach can yield big returns if investors target quality stocks. 5 Best Performing Bank Stocks in 2012
Shanthi Bharatwaj
Hopes that the European crisis might not have a significant impact on the U.S. economy and expectations that there will be greater clarity on the regulatory front have helped turn the tide for bank stocks. Stocks Reverse Course on Bernanke Testimony
Chao Deng
Less dovish comments from Fed chief Ben Bernanke steal the market's momentum from earlier positive reads on economic growth and business activity. Bank of America, AIG Get Upgrades
Alexandra Zendrian
These stocks receive upgrades from TheStreet Ratings on Wednesday. Analysts' Actions: AAPL, VPHM, CVX
TheStreet Staff
Here are today's top research calls. 5 Bank Stocks That Won't Bankrupt You or America (Update 1)
Philip van Doorn
Many of this year's best bank stock performers have still not recovered from their 2011 losses. These five quality names have lagged the financial sector so far this year, but performed well last year, highlighting the group's lower relative risk.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
